Bangalore-based online medical consultation platform, DocsApp, has raised $1.2 Million in seed funding from Facebook’s angel investors Anand Rajaraman and Venky Harinarayan, along with Japanese Venture Capital firm Rebright Partners.
DocsApp,Founded in 2015 by IIT Madras Alumni Satish Kannan and Enbasekar D, is an online doctor consultation application that seeks to make sure that doctors are easily accessible to the patients. The application lets patients consult a range of specialists on a variety of illnesses ranging from Psychiatry to Derma, Gynecologist, Pediatrics and General Medicines, Weight Management, Sexology, Gastroenterology etc.
Patients can chat with the doctor and also share pictures and reports of the ailment with the doctors privately. DocsApp claims that their product has been designed to give the best experience to patients with complete privacy.
Majority of DocsApp users have come from major cities like Bengaluru, Delhi, NCR, Mumbai, Chennai and Hyderabad.
Talking about the need for DocsApp, Satish (CEO), said,
It’s estimated that up to 70 percent of the most common health issues people face can be managed online. The patient doesn’t need to travel to have a medical consultation. We want to bridge the gap between patients and doctors through this platform so that people can get expert consultation on demand. We believe that this will also help us take specialised care downstream to more remote areas across the country.
DocsApp records over 80,000 app downloads with more than 15,000 patients taking consultation every month.
Speaking about investment in DocsApp, Anand Rajaraman & Venky Harinarayan said,
“The DocsApp team has created an amazing app that combines whiz-bang technology with specialist doctors to enable speedy doctor consultations and great patient outcomes. This app will revolutionize primary healthcare in India!”
Founding General Partner of Rebright Partners, said,
“The team has a great understanding of the healthcare space and it is a scalable business model that can service millions of patients across India and SouthEast Asia.”
The app is available for both Android and iOS platforms.